Pharma R&D Today

Ideas and Insight supporting all stages of Drug Discovery & Development

Select category
Search this blog

Life Sciences trends that make me excited for 2020 (and beyond)

Posted on January 20th, 2020 by in Pharma R&D

Beginning a new year offers an important opportunity to reflect on the past one. I’ve been thinking a lot about what I learned in 2019, and where I believe my industry is going as we continue further into 2020.

(more…)

Amsterdam goes all-in on AI

Posted on January 17th, 2020 by in Pharma R&D

Artificial intelligence are the words on everyone’s lips these days. Across industries, AI is driving some of today’s most exciting innovations and is poised to be ubiquitous in the future. But success in AI demands investment, and now is the time to put up those funds in order to secure the brightest minds and best companies. That’s why Amsterdam’s educational institutions and knowledge centers are joining forces and pledging one billion euros for AI.

(more…)

Finding the Corpus of Knowledge for Machine Learning/AI In Chemistry

Posted on January 14th, 2020 by in Chemistry

Machine learning for predicting chemistry is an area of intense research and publication. However, since the terminology used to describe this activity is diverse it can be difficult to identify all of the publications describing use of computers to predict chemical outcomes or retrosynthesis paths.

(more…)

What’s ahead for the Life Sciences industry?

Posted on December 30th, 2019 by in Pharma R&D

As the year comes to a close, we’re thinking about trends in the landscape and where the industry is headed. What do some of the members of Elsevier’s Life Sciences team think?

Tom Pianko VP of Global Key Accounts, counts machine learning, artificial intelligence, data normalization and advance analytics tools among the trends that point to where the Life Sciences industry is going—and many of his colleagues agree.

(more…)

  1. 1
  2. 2
  3. 3
  4. 4
  5. …
  6. 9